Skip to main content
Equibles

WINTON GROUP Ltd

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 1612063 LONDON, X0
Back to RXRX Full portfolio

Position in RXRX

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$707,576
+$387,989 QoQ
Shares Held
192,800
+85.2% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#90
of 344 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RXRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WINTON GROUP Ltd holds $97,029,578 across 91 Biotechnology names. RXRX ranks #29 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INCY
Incyte Corp
 254,408 $28,839,690
2 FTRE
Fortrea Holdings Inc.
 389,155 $6,771,297
3 EXEL
Exelixis, Inc.
 99,834 $5,431,967
4 TECH
BIO-TECHNE Corp
 67,227 $4,749,587
5 HALO
Halozyme Therapeutics, Inc.
 60,348 $4,723,437
6 VKTX
Viking Therapeutics, Inc.
 90,546 $3,532,199
7 ALNY
Alnylam Pharmaceuticals, Inc.
 7,880 $2,372,116
8 TRVI
Trevi Therapeutics, Inc.
 106,852 $1,992,789

All Filings in RXRX

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $707,576 192,800
2026-03-31 $319,587 104,100